A new analyst report values the potential for a medically focussed cannabis producer after suffering a reversal in a potential merger.

Greg McLeish, analyst with Mackie Research Capital covering the cannabis space issued a new research data report stamping WeedMD (TSX:WMD) with a one-year price target of C$4 and retained his “Buy” rating.


McLeish highlighted the company’s current cash situation and said its funded capacity provides a strong asset.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

“This strong cash position will also allow management to pursue strategic acquisitions and address potential working capital requirements,” McLeish wrote, according to Cantech Letter.

WeedMD was stuck in a business turnabout from Hiku Brands (CSE:HIKU), a company with which it held an arrangement to essentially merge both businesses.

As the deal continued to move forward, Canopy Growth (TSX:WEED; NYSE:CGC) entered the picture with an acquisition offer for Hiku.

“Ultimately, together we [Canopy and Hiku] will continue to build one of the world’s most engaging and successful cannabis retail and brand business,” Alan Gertner, CEO of Hiku said in a statement.

Thanks to the annulment from Hiku, WeedMD obtained a C$10 million termination fee, which the company highlighted as part of its cash position.

WeedMD’s stock declined immediately following the announcement from Canopy and Hiku, and continued with the company reaching a C$1.49 price point per share from its previous close on Tuesday (July 17).

Since the Hiku reversal on July 10, WMD has declined in price 27.32 percent.

McLeish’s new projection comes after endorsing the original merger with Hiku in a previous note.

Investor takeaway

Support from the financial community for WeedMD shows a strong foundation from the cannabis producer as it recovers and begins searching a potential new entry into the recreational cannabis space.

WeedMD will now have to deliver on its business strategy for investors to return to its side following the decline of the Hiku reversal.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Hiku Brands is a client of the Investing News Network. This article is not paid-for content.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Harvest Health & Recreation Inc. (“Harvest”) ( CSE: HARV OTCQX: HRVSF ), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the opening of a new medical dispensary in Kissimmee, Florida .

Keep reading... Show less

Adastra Holdings Ltd. (formerly Phyto Extractions Inc.) (CSE: XTRX) (FRA: D2EP) (” Adastra ” or the ” Company “) is pleased to announce that it has entered into a share purchase agreement dated September 15, 2021 (the ” Share Purchase Agreement “) pursuant to which the Company has agreed to acquire all the issued and outstanding shares of 1204581 B.C. Ltd., doing business as Phyto Extractions (” Phyto Extractions “) from the shareholders (each, a ” Vendor “) of Phyto Extractions (the ” Acquisition “).

Keep reading... Show less
  • Four SKUs of Pura Earth branded dermacosmetics have been successfully registered with ARCSA, imported into Ecuador, and will be distributed and commercialized through previously announced partnership with Spenta S.A.
  • This marks the 12 th country and market opening of Avicanna’s product offerings.

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/

Avicanna Inc. (” Avicanna ” or the ” Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that it has completed product registration and its first commercial export of its Pura Earth branded dermacosmetics products in Ecuador.

Keep reading... Show less

The Canadian Securities Exchange (“CSE” or “the Exchange”) today announced its market statistics for the month of August 2021, which was highlighted by large financings in the cannabis and mining sectors.

August 2021 Operating Statistics

Keep reading... Show less

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Company”) today announced the voting results from its annual general and special meeting of shareholders held on September 14, 2021 (the “Meeting”).

Keep reading... Show less